Letters to the Editor
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: January 22, 2024
Accepted: February 3, 2024
Accepted: February 3, 2024
547
Views
970
Downloads
70
HTML
Authors
Downloads
Download data is not yet available.
Citations
Kim K, Phelps MA. Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab. Clin Pharmacokinet. 2023 Jun;62(6):789-806. doi: 10.1007/s40262-023-01240-8. Epub 2023 May 2. PMID: 37129750; PMCID: PMC10760401.
Paul B, Hamadeh I, Atrash S, Bhutani M, Voorhees P, Usmani SZ. Daratumumab subcutaneous formulation for the treatment of multiple myeloma. Expert Opin Biol Ther. 2020 Nov;20(11):1253-1259. doi: 10.1080/14712598.2020.1806231. Epub 2020 Aug 16. PMID: 32750265.
De Angelis G., Fiorini A., Trapè G., Panichi V., Chavez M.G., Emanueli Cippitelli E., Innocenti V., Perazzini R., Talucci R., Topini G., Di Veroli A., Mercanti C., Natalino F., Tarnani M., Morucci M., Mastini C., Silvestri A., Andriani A., Montanaro M., Ciambella S., Latagliata R.: Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report, Blood (2023) 142 (Supplement 1): 7242.
Sanguinetti JM, Martínez D, Dimase F, Streich G, Castro P, Vega V, Batagelj E. Patient Safety and Satisfaction in Home Chemotherapy. Home Healthc Now. 2021 May-Jun 01;39(3):139-144. doi: 10.1097/NHH.0000000000000958. PMID: 33955927.
Lüthi F, Fucina N, Divorne N, Santos-Eggimann B, Currat-Zweifel C, Rollier P, Wasserfallen JB, Ketterer N, Leyvraz S. Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies. Support Care Cancer. 2012 Mar;20(3):575-81. doi: 10.1007/s00520-011-1125-9. Epub 2011 Mar 8. PMID: 21384139.
Joo EH, Rha SY, Ahn JB, Kang HY. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer. Support Care Cancer. 2011 Jul;19(7):971-8. doi: 10.1007/s00520-010-0917-7. Epub 2010 May 23. PMID: 20496154.
Supporting Agencies
NoneHow to Cite
“Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024030. doi:10.4084/MJHID.2024.030.
Copyright (c) 2024 alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
